standOff. When we have changed our mind. Some entries in the table begin with a word in capitals and the reason for it. EVIDENCE CORRECTED — the finding still stands, but we had quoted the wrong sentence from the paper, and the quotation has been replaced with the right one. RETRACTED — the entry itself was wrong; it stays on the page, marked, with the reason, rather than being deleted. WITHDRAWN AND REPLACED — the entry was wrong, and a corrected version of it appears in the entries below. Each mark carries its own reason, in brackets, because the reasons differ from one entry to the next. An entry we have WITHDRAWN is removed from this page and kept in the record, with its reason. A line reading Audit and a date is a later re-reading of the entry against its whole sentence: DOUBTFUL means it was kept, and the reason says what is loose about it. Quotation marks inside the tagger's sentence. Where a tag is the tagger's own sentence, a phrase in quotation marks inside it is borrowed from the paper — the tagger's wording around it is not. The paper's own sentence is the evidence quote shown on the same row, so the borrowing can be checked against the thing borrowed from without leaving this page. Nothing inside quotation marks anywhere on this page is ours: if it is quoted, it is the paper's. Whose words a concept carries. A concept entry records a term the paper itself uses, so the term, the sense given for it, and its evidence are the paper's own words, quoted where the paper fixes them. This is the opposite of a sense entry in the tag table, which is the tagger's sentence about how the paper uses a term. Where a concept entry could not be grounded in the paper's words, the entry says so on its own row.| relation to other work | claim_relations | how this paper stands to another: agrees, contradicts, extends, qualifies |
| claim type | claim_type | the shape of the claim: existence, mechanism, method, critique, prediction, null |
| concept edge | concept_edges | an asserted relation between two concepts, with the sentence asserting it |
| concept | concepts | an idea the paper works with, quoted where the paper uses it |
| content tag | content_tags | a finding, definition, quantity, statistic or variable named in the paper |
| contribution | contribution | what the paper claims to add |
| control | controls | an experiment run to eliminate a rival explanation |
| limitation | limitations | what the paper says its evidence cannot support |
| mechanism | mechanisms | how the reported effect is said to come about |
| method | method | how the paper produced its evidence |
| object of study | object_of_study | what the paper is about — the thing it investigates |
| phenomenon | phenomenon | the effect or regularity under study |
| research question | research_question | the question the paper sets itself |
| sense | senses | a distinct use of a term, quoted where the paper fixes it |
The reference list is not part of the text we hold for this paper. Our copy was extracted from the publisher's page and the bibliography did not survive that extraction, so the article below ends before its references. Nothing has been removed by us.
33 bmcgeri BMC Geriatrics BMC Geriatr BMC PMC5635569 5635569 5635569 29017448 10.1186/s12877-017-0621-2 What is polypharmacy? A systematic review of definitions Masnoon Nashwa 1 2 ✉ Shakib Sepehr 3 4 Kalisch-Ellett Lisa 1 Caughey Gillian E 1 3 4 1 Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Frome Road, Adelaide, South Australia Australia 2 Department of Pharmacy, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia Australia 3 Department of Clinical Pharmacology, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia Australia 4 Discipline of Pharmacology, School of Medicine, University of Adelaide, North Terrace, Adelaide, South Australia Australia ✉ Corresponding author.
10 10 2017 17 230 230 18 10 2017 © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Abstract
Background
sensesMultimorbidity and the associated use of multiple medicines (polypharmacy), is common in the older population. Despite this, there is no consensus definition for polypharmacy. A systematic review was conducted to identify and summarise polypharmacy definitions in existing literature.
Methods
The reporting of this systematic review conforms to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist. MEDLINE (Ovid), EMBASE and Cochrane were systematically searched, as well as grey literature, to identify articles which defined the term polypharmacy (without any limits on the types of definitions) and were in English, published between 1st January 2000 and 30th May 2016. Definitions were categorised as i. numerical only (using the number of medications to define polypharmacy), ii. numerical with an associated duration of therapy or healthcare setting (such as during hospital stay) or iii. Descriptive (using a brief description to define polypharmacy).
Results
A total of 1156 articles were identified and 110 articles met the inclusion criteria. mechanismsconcepts↗Articles not only defined polypharmacy but associated terms such as minor and major polypharmacy. As a result, a total of 138 definitions of polypharmacy and associated terms were obtained. There were 111 numerical only definitions (80.4% of all definitions), 15 numerical definitions which incorporated a duration of therapy or healthcare setting (10.9%) and 12 descriptive definitions (8.7%). The most commonly reported definition of polypharmacy was the numerical definition of five or more medications daily ( n = 51, 46.4% of articles), with definitions ranging from two or more to 11 or more medicines. mechanismsOnly 6.4% of articles classified the distinction between appropriate and inappropriate polypharmacy, using descriptive definitions to make this distinction.
Conclusions
limitationsPolypharmacy definitions were variable. Numerical definitions of polypharmacy did not account for specific comorbidities present and make it difficult to assess safety and appropriateness of therapy in the clinical setting.
Keywords: Polypharmacy, Multimorbidity, Comorbidity, Inappropriate prescribing, Aged, Systematic review
status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Received 2017 May 15; Accepted 2017 Oct 2; Collection date 2017.
Background
Multimorbidity, commonly defined as the co-existence of two or more chronic health conditions, is common in the older population [ 1 ]. The presence of multiple chronic conditions increases the complexity of therapeutic management for both health professionals and patients, and impacts negatively on health outcomes. Multimorbidity is associated with decreased quality of life, self-rated health, mobility and functional ability as well as increases in hospitalisations, physiological distress, use of health care resources, mortality and costs [ 2 – 4 ]. Globally, the health burden of multimorbidity is expected to rise significantly as a result of the growing number of older people and increasing numbers of people living with multimorbidity [ 5 ].
The use of multiple medicines, commonly referred to as polypharmacy is common in the older population with multimorbidity, as one or more medicines may be used to treat each condition. Polypharmacy is associated with adverse outcomes including mortality, falls, adverse drug reactions, increased length of stay in hospital and readmission to hospital soon after discharge [ 6 – 8 ]. The risk of adverse effects and harm increases with increasing numbers of medications [ 9 ]. Harm can result due to a multitude of factors including drug-drug interactions and drug-disease interactions. Older patients are at even greater risk of adverse effects due to decreased renal and hepatic function, lower lean body mass, reduced hearing, vision, cognition and mobility [ 10 ].
While in many instances the use of multiple medicines or polypharmacy may be clinically appropriate, it is important to identify patients with inappropriate polypharmacy that may place patients at increased risk of adverse events and poor health outcomes. Studies have suggested a shift towards adopting the term ‘appropriate polypharmacy’ in order to differentiate between the prescribing of ‘many’ and ‘too many’ drugs instead of a simple numerical count of medications, which is of limited value in practice [ 11 , 12 ]. In order to make this distinction between appropriate and inappropriate polypharmacy, the term polypharmacy needs to be clearly defined. We therefore conducted a systematic review to explore the definitions of polypharmacy in existing literature. We additionally aimed to explore whether articles differentiated between appropriate and inappropriate polypharmacy and how this distinction was made.
Methods
Data sources and search strategy
The reporting of this systematic review conforms to the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) checklist.
MEDLINE (Ovid), EMBASE and Cochrane databases were searched between 1st January 2000 and 30th May 2016.
The following search terms (Medical Subject Headings or MESH and keywords) were used in EMBASE and MEDLINE (Ovid):
polypharmacy/ (MESH) OR multiple medication* OR multiple medicine* OR multiple drug* (key words) OR many medication* OR many medicine* OR many drug* (key words) (for all articles referring to polypharmacy) AND.
defin* (key word) or explan* (keyword) (for all articles defining or explaining polypharmacy).
For the review of the Cochrane database, the term “polypharmacy” was searched.
The search was limited to primary research articles which defined the term polypharmacy in any shape or form, conducted in humans and published in English between the years 2000 and 2016. Articles were considered if the abstracts were available in English and were published or in press. Reference lists of relevant articles and grey literature were screened to identify other relevant articles. The search strategy was developed in consultation with a librarian specialising in health databases, with a pre-determined protocol developed collaboratively with the authors for methods to search and select relevant articles.
Study selection and data extraction
Articles that met the inclusion criteria and provided a definition of polypharmacy were included. One author (NM) conducted the initial database search and primary screening of article titles and abstracts and articles were categorised as: relevant, irrelevant or unsure. Three reviewers (NM, SS, GC) discussed the appropriateness of inclusion of each article classed as relevant or unsure. Once all relevant articles were identified, one author (NM) reviewed full texts of all identified articles and extracted the data. A pre-defined data extraction template was developed by all authors and then applied to ensure consistent data extraction from each of the identified studies. Data items extracted included the definitions of polypharmacy and associated terms such as minor, moderate and excessive polypharmacy and whether studies distinguished between appropriate and inappropriate polypharmacy and if so, how this distinction was made or defined. The definitions of polypharmacy and associated terms were categorised as: i. numerical only (using the number of medications to define polypharmacy), ii. numerical for a given duration of therapy or healthcare setting for e.g. during hospital stay or iii. Descriptive (using a brief description to define polypharmacy). Once the primary data extraction was complete all authors reviewed the content analysis for each of the extracted studies, with data further categorised and summarised in tables.
Results
A total of 1156 articles were identified and 110 articles met the full inclusion criteria for this systematic review [ 10 – 119 ]. Fig. 1 shows a flowchart of study selection according to the PRISMA checklist.
Fig. 1 Study selection flowchart according to PRISMA checklist
object_of_studycontributionmechanismscontent_tagscontent_tagscontent_tags↗Studies not only defined polypharmacy but also used associated terms to define the level of polypharmacy; including minor (8 studies, 7.3%), moderate (1 study, 0.9%), major (12 studies, 10.9%), hyper (2 studies, 1.8%), excessive (10 studies, 9.1%), severe (1 study, 0.9%), appropriate (1 study, 0.9%), rational polypharmacy and indiscriminate prescribing (1 study, 0.9%), persistent (1 study, 0.9%), chronic (1 study, 0.9%), and pseudopolypharmacy (1 study, 0.9%). As a result, a total of 138 definitions of polypharmacy and associated terms were obtained. There were 111 numerical only definitions (80.4% of all definitions), 15 numerical definitions which incorporated a duration of therapy or healthcare setting (10.9%) and 12 descriptive definitions (8.7%). Table 1 presents a breakdown of the number of definitions for each term.
Table 1 Breakdown of polypharmacy definitions according to the category of definition
Term Numerical only Numerical in a given duration of time or setting Descriptive Total number of definitions
Polypharmacy 81 9 9 99
Minor Polypharmacy 8 0 0 8
Moderate polypharmacy 1 0 0 1
Major polypharmacy 11 1 0 12
Hyperpolypharmacy 1 1 0 2
Excessive polypharmacy 8 2 0 10
Severe polypharmacy 1 0 0 1
Persistent polypharmacy 0 1 0 1
Chronic polypharmacy 0 1 0 1
Appropriate polypharmacy 0 0 1 1
Rational polypharmacy and indiscriminate prescribing 0 0 1 1
Pseudopolypharmacy 0 0 1 1
Total number of definitions according to category of definition 111 15 12 138
Out of the 110 identified articles, 81 (73.6%) included only a numerical definition of polypharmacy (i.e. did not specify duration of therapy or healthcare setting). Nine articles (8.2%) included numerical definitions of polypharmacy for a given duration of time or healthcare setting and nine articles (8.2%) included descriptive definitions of polypharmacy. Four articles included two categories of polypharmacy definitions: two articles (1.8%) included both numerical only definitions and numerical definitions of polypharmacy for a duration of time or healthcare setting and two articles (1.8%) included both numerical only and descriptive definitions of polypharmacy.
Numerical only definitions of polypharmacy in existing literature
Table 2 shows the various numerical only categorisations of polypharmacy and associated terms and the number of studies using these definitions.
Table 2 Various numerical only definitions of polypharmacy and associated terms in existing literature
Term Number of medications Number of studies References
Polypharmacy ≥ 2 1 [ 13 ]
2 to 9 1 [ 14 ]
≥ 3 1 [ 15 ]
3 to 6 1 [ 16 ]
≥ 4 6 [ 17 – 22 ]
≥ 4 or ≥ 5 1 [ 23 ]
≥ 5 51 [ 11 , 24 – 73 ]
≥ 6 10 [ 10 , 74 – 82 ]
≥ 7 2 [ 83 , 84 ]
5 to 9 3 [ 85 – 87 ]
≥ 9 1 [ 88 ]
≥ 10 1 [ 89 ]
≥ 11 1 [ 90 ]
number of drug classes 1 [ 91 ]
Minor Polypharmacy 2 to 4 6 [ 92 – 97 ]
2 to 3 1 [ 98 ]
0 to 4 1 [ 99 ]
Moderate polypharmacy 4 to 5 1 [ 98 ]
Major polypharmacy ≥ 5 6 [ 92 – 95 , 97 , 100 ]
≥ 6 3 [ 96 , 98 , 101 ]
5 to 9 1 [ 99 ]
≥ 11 1 [ 74 ]
Hyperpolypharmacy ≥ 10 1 [ 102 ]
Excessive polypharmacy ≥ 10 7 [ 30 , 58 , 65 , 70 , 85 – 87 ]
≥ 21 1 [ 74 ]
Severe polypharmacy ≥ 10 1 [ 99 ]
mechanismsconcepts↗sensescontent_tagscontent_tags↗content_tagscontent_tagsThere was a wide range of variability in the definitions of polypharmacy as well as associated terms such as minor, moderate and major polypharmacy. The most commonly used term was polypharmacy, but there was variation with regard to the actual definition of polypharmacy, which ranged from two or more medications to 11 or more medications [ 13 , 90 ]. The most commonly used definition for polypharmacy was five or more medications daily, with 46.4% ( n = 51) of studies using this definition [ 11 , 24 – 73 ]. The second most common definition for polypharmacy was six or more medications, with ten studies using this definition [ 10 , 74 – 82 ]. Only one study defined polypharmacy as the number of drug classes used by a patient [ 91 ].
Numerical definitions of polypharmacy incorporating a duration of therapy or healthcare setting
Eleven studies (10.0% of all studies) used numerical definitions of polypharmacy which incorporated a duration of therapy in the definition and four studies (3.6%) used definitions of polypharmacy which incorporated a healthcare setting (Table 3 ). The definitions of polypharmacy involving a duration of therapy, ranged from use of two or more medications for more than 240 days (‘long term use’) to five to nine medications used for 90 days or more [ 101 , 108 ]. Polypharmacy definitions incorporating a healthcare setting included the use of five or more medications at hospital discharge, and the use of 10 or more medications during hospital stay [ 106 , 110 ].
Table 3 Numerical definitions of polypharmacy and associated terms by duration of therapy/ healthcare setting
Term Number of medications Number of studies References
Polypharmacy ≥ 2 for > 240 days (long term) 1 [ 101 ]
≥ 5 medications in the same month 1 [ 103 ]
> 5 medications for ≥ 90 days 1 [ 104 ]
≥ 5 medications in the same quarter of a year 1 [ 105 ]
≥ 5 medicines at hospital discharge 1 [ 106 ]
5 to 9 medicines on the day of maximum number of prescriptions of the study year (on the day of the study year when the number of medications prescribed was highest) 1 [ 107 ]
5 to 9 medications for ≥ 90 days 1 [ 108 ]
5 to 9 medicines during hospital stay 1 [ 109 ]
≥ 10 medicines during hospital stay 1 [ 110 ]
Major polypharmacy ≥ 10 on the day of maximum number of prescriptions of the study year (on the day of the study year when the number of medications prescribed was highest) 1 [ 107 ]
Hyperpolypharmacy ≥ 10 medications for ≥90 days 1 [ 108 ]
Excessive polypharmacy ≥ 10 medications in the same quarter of a year 1 [ 105 ]
≥ 10 medications during hospital stay 1 [ 109 ]
Persistent polypharmacy ≥ 5 medications for 181 days 1 [ 52 ]
Chronic polypharmacy ≥ 5 medications in 1 month for 6 months (consecutive or not) in a year 1 [ 111 ]
Descriptive definitions of polypharmacy
Twelve studies used descriptive definitions of polypharmacy (Table 4 ). mechanismscontrolsSome studies used different wording but conveyed the same definition of polypharmacy. For example, the definitions “Co-prescribing multiple medications” [ 113 ] and “Simultaneous and long term use of different drugs by the same individual” [ 77 ] describe polypharmacy as the use of multiple medications concurrently. Other studies alluded to a different issue of medications being appropriate or inappropriate for a given patient [ 10 , 79 , 114 – 118 ].
Table 4 Descriptive definitions of polypharmacy and associated terms
Term Definition Number of studies References
Polypharmacy Patients visiting multiple pharmacies to obtain medications 1 [ 112 ]
Coprescribing multiple medications 1 [ 113 ]
Simultaneous and long term use of different drugs by the same individual 1 [ 77 ]
Polypharmacy definition ranges from the use of a large number of medications, to the use of potentially inappropriate medications, medication underuse and medication duplication 1 [ 114 ]
Potentially inappropriate medications 2 [ 10 , 79 ]
Use of multiple medications concurrently and the use of additional medications to correct adverse effects 1 [ 115 ]
Use of medications which are not clinically indicated 1 [ 116 ]
More drugs being prescribed or taken than are clinically appropriate in the context of a patient’s comorbidities 1 [ 12 ]
Appropriate polypharmacy Optimisation of medications for patients with complex and/or multiple conditions where medicine usage agrees with best evidence 1 [ 117 ]
Rational polypharmacy and indiscriminate prescribing mechanismscontent_tagsRational polypharmacy recognizes legitimate prescribing and indiscriminate prescribing suggests inappropriate prescribing (the terms “legitimate prescribing” and “inappropriate prescribing” were not explained) 1 [ 118 ]
mechanismsconcepts↗sensescontent_tags↗Pseudopolypharmacy Patients being recorded as taking more medications than they are actually taking 1 [ 119 ]
Appropriate and inappropriate polypharmacy
research_questionlimitationscontent_tagsOnly seven studies (6.4% of all studies) defined appropriate or rational polypharmacy, or recognised the distinction between appropriate and inappropriate medications [ 10 , 79 , 114 – 118 ]. These studies either defined polypharmacy using a brief description only ( n = 3) [ 79 , 115 , 117 ] or used a brief description and polypharmacy tools such as the Beers criteria and the Medication Appropriateness Index (MAI) ( n = 4 studies) [ 10 , 114 , 116 , 118 ]. An example of a polypharmacy definition which recognised the use of appropriate and inappropriate medications is “polypharmacy ranges from the use of a large number of medications, to the use of potentially inappropriate medications, medication underuse and duplication” and “potentially inappropriate medications” [ 114 ]. Out of the two studies defining polypharmacy as “potentially inappropriate medications”, one study simply mentioned “potentially inappropriate medications” without further explanation [ 79 ] and the other study included examples of potentially inappropriate medications from existing literature such as duplication of medications, drug-drug interactions, medications used to treat side effects of other medications and medications which are unnecessary for a specific patient [ 10 ]. Only one study explicitly defined appropriate polypharmacy, which was defined as “the optimisation of medications for patients with complex and/or multiple conditions where medicine usage agrees with best evidence” [ 117 ].
Four studies (3.6%) used polypharmacy tools or criteria to identify potentially inappropriate medications [ 10 , 114 , 116 , 118 ]. The Beers criteria as an indicator of potentially inappropriate medications were used in all four (three studies used Beers criteria 2003 and one used Beers criteria 1997) [ 10 , 114 , 116 , 118 ]. One study used the Medication Appropriateness Index (MAI) and the Healthcare Effectiveness Data and Information Set (HEDIS) [ 114 ]. None of the studies explicitly identified the need to distinguish between appropriate and inappropriate polypharmacy based on the pharmacology of medications involved, how they interact with each other and comorbidities for a specific patient.
phenomenonmechanismssensesclaim_relationscontent_tagscontent_tagsOf the 110 studies included in the review, only one highlighted the inconsistencies in the definitions of polypharmacy in the literature. The authors of this study suggested that polypharmacy be defined as patients visiting multiple pharmacies which may be associated with safety concerns relating to potential outcomes such as medication duplication, drug-drug interactions and adverse effects [ 112 ].
Discussion
The results of this systematic review show that there is large heterogeneity in the definition of polypharmacy; ranging from numerical counts only, numerical counts for a given duration of therapy or setting or descriptive, which included terms such as minor, moderate, major and excessive polypharmacy. The lack of a clear and universal definition of polypharmacy as well as terms such as minor, moderate major polypharmacy makes it challenging for healthcare professionals to assess and consider efficacy and safety issues within the clinical setting.
concepts↗concept_edgesThe most commonly reported category of definitions for polypharmacy and associated terms was numerical only. The most commonly used term was polypharmacy which was defined as five or more medications by 46.4% of studies (51 articles). There was a wide range of numerical only definitions of polypharmacy, ranging from two or more medications to 11 or more medications. mechanismsclaim_relationscontent_tagsHowever, the clinical basis for using a numerical count such as five or more medications to define polypharmacy and the potential of this to rationalise medication use and optimise health outcomes is not elucidated in most studies. It has been postulated that while the term polypharmacy has evolved over time, the basis for the definition is simply more drugs being prescribed or taken than are clinically appropriate in the context of a patient’s comorbidities [ 12 ]. mechanismsconcepts↗concepts↗concept_edgescontent_tags↗It is commonly reported that as the number of prescribed drugs increases, so do the chances of adverse drug events and likelihood of harm [ 120 ]. However, the specific number of drugs taken is not itself indicative of appropriateness of therapy as all of the drugs may be clinically necessary and appropriate for the patient. Despite this, only one study argued that instead of using numerical counts of medications, clinicians should identify appropriateness of therapy, where potential benefits outweigh the potential harms [ 121 ]. mechanismsconcepts↗concepts↗sensesconcept_edgescontent_tags↗There is a clear need towards adopting the term ‘appropriate polypharmacy’ in order to differentiate between the prescribing of ‘many’ and ‘too many’ drugs instead of a simple numerical count of medications, which is of limited value in practice [ 11 , 12 , 120 – 122 ].
mechanismssensescontent_tagsWhilst the addition of duration of therapy or healthcare setting to a count of medicines in the definition of polypharmacy provided more specific definitions, it did not provide any further clarity or consistency. Five or more medications were again used in the definitions but with a period of time attached such as 90 days or more [ 104 ]. The use of duration in the definitions appeared to be included to identify those patients with longer term or chronic use of medications, potentially identifying those patients who might be at greatest risk of medication-related problems. Definitions incorporating a healthcare setting commonly used five or more medications as the count, but using a setting such as at the time of hospital discharge [ 106 ].These definitions were largely based on the dispensing data available to assess prevalence and incidence of polypharmacy, rather than an evidence based approach of determining appropriateness of therapy; the setting provided little addition to existing definitions of polypharmacy in a clinical sense of medication rationalisation and minimisation of harm.
A recent commentary on polypharmacy stated that while a large body of literature confirms the fact that patients are increasingly taking large numbers of medications, numerical definitions of polypharmacy do not ascertain the clinical appropriateness of therapy and the process of rationalising those medications [ 123 ]. The author argued that when each of the medications can be linked to practice guidelines for chronic conditions for a given patient, using a numerical cut-off to define polypharmacy becomes irrelevant. While the number of medications can be a starting point, medications should be assessed in terms of their indication, efficacy and potential for harm with each other (not in isolation) given pharmacokinetic and pharmacodynamics interactions, in order to facilitate deprescribing of inappropriate medications [ 123 , 124 ]. Medications should be assessed for risks and benefits and the final combination of medications should be based on benefits outweighing the risks [ 124 , 125 ]. Current literature is alluding to looking beyond single disease management guidelines and considering the patient’s complete scenario by considering all comorbidities and medications being prescribed for a given patient to consider the patient as a whole and focusing on improving the overall health [ 11 , 12 , 117 , 120 – 122 , 125 ].
While the use of multiple medicines may be clinically appropriate for some patients, it is important to identify those patients who may be at risk of adverse health outcomes as a result of inappropriate polypharmacy. Only seven studies recognised the distinction between appropriate and inappropriate polypharmacy. This is crucial to facilitate the deprescribing of inappropriate medications and optimal use of appropriate medications. Consideration of comorbid conditions and other medications is required to make definitions clinically relevant, to facilitate medication assessment and rationalisation in every day practice. While a small number of studies (3.6%) used polypharmacy tools or criteria including the Beers criteria, MAI and HEDIS to identify potentially inappropriate medications to detect potentially inappropriate medications, the limitations of the tools and criteria in the everyday clinical setting were recognised [ 10 , 114 , 116 , 118 ].The Beers criteria which was used in all four studies identified, is a commonly used prescribing assessment tool based on a list of potentially inappropriate medications to be avoided in the older population [ 126 , 127 ]. However, it has recognised limitations such as requiring regular updates to ensure clinical relevance and including a list of outdated medications which may not be used in practice at that time.
Strengths and limitations
Strengths of this systematic review include the novelty of summarising the range of polypharmacy definitions available in literature. A comprehensive search strategy of three large and reliable databases (MEDLINE, EMBASE and Cochrane) was used, meaning that it is likely that all relevant articles were identified.
method↗limitationscontrolscontrolsA limitation of this review is the inclusion of studies in English only which can cause information bias. While EMABSE, MEDLINE (Ovid) and Cochrane databases were searched, the absence of other databases such as Scopus could have introduced selection bias. Additionally articles from the year 2000 until present have been included. There may be clinically relevant definitions for polypharmacy which were added to literature prior to 2000 which have not been included in this review. While authors discussed the inclusion criteria and data being extracted, there is still the potential for confusion bias.
Conclusions
claim_typelimitationsWhile the most commonly used definition of polypharmacy is being on five or more medicines, definitions are variable, which can cause confusion for researchers as well as clinicians in practice. Numerical definitions of polypharmacy do not account for specific comorbidities present and make it difficult to assess safety and appropriateness of therapy in the clinical setting. There is a need for an internationally agreed definition of polypharmacy. The results indicate the need for a shift towards the term ‘appropriate polypharmacy’ using a holistic approach of assessing medication use in context of comorbidities present, according to best available evidence in order to optimise health outcomes.
Acknowledgements
Not applicable.
Funding
NM is supported by an Australian Government Research Training Program (RTP).
Availability of data and materials
Majority of data generated or analysed during this study are included in this published article. Any other datasets during and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
HEDIS Healthcare Effectiveness Data and Information Set
MAI Medication Appropriateness Index
PRISMA Preferred Reporting Items for Systematic reviews and Meta-Analyses
Authors’ contributions
NM conducted the primary screening of article titles and abstracts and categorisation of articles as: relevant, irrelevant or unsure. Articles which were categorised as ‘unsure’ were discussed with SS and GC. The final list of relevant articles was formed by consensus amongst all authors. Once all relevant articles were identified, NM reviewed full texts of all identified articles and categorised the different polypharmacy definitions. NM, SS, LK and GC made substantive intellectual contributions to the conception and design of the study as well as interpretation of data. NM drafted the initial manuscript and all authors were involved in critically reviewing and revising the manuscript. All authors read and approved the final manuscript and agreed to be accountable for all aspects of the work.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Nashwa Masnoon, Email: Nashwa.Masnoon@mymail.unisa.edu.au.
Sepehr Shakib, Email: Sepehr.Shakib@sa.gov.au.
Lisa Kalisch-Ellett, Email: Lisa.Kalisch@unisa.edu.au.
Gillian E. Caughey, Email: Gillian.Caughey@unisa.edu.au
Relations on this page carry a quotation for the claim. Where a relation was separately evidenced — and so tested against the vocabulary for its type — the row says so; 3 of 3 relations here carry that mark. The rest are the tagger’s reading of the sentence quoted beside them.
| facet | tag | field | conf. | whose words |
|---|---|---|---|---|
| object_of_study | THE DEFINITIONS THEMSELVES - a systematic review whose unit of analysis is not a patient or an outcome but a DEFINITION, counting how many are in use for one word and what each of them says | object_of_study | the paper's words | |
| research_question | what polypharmacy means in the published literature, and whether any article distinguishes appropriate from inappropriate polypharmacy | research_question | the paper's words | |
| contribution | 138 definitions of polypharmacy and its derived terms, extracted from 110 articles and classified as numerical only, numerical-with-duration-or-setting, or descriptive - with the full range of thresholds and the share of studies using each | contribution | the paper's words | |
| claim_type | critique | claim_type | the paper's words | |
| phenomenon | a term in universal clinical use whose threshold varies five-fold between studies, and whose users almost never notice | phenomenon | the paper's words | |
| method | systematic-review also in: systematic-review | method | the paper's words | |
| mechanisms | 138 DEFINITIONS OF ONE TERM AND ITS FAMILY, FROM 110 ARTICLES: `a total of 138 definitions of polypharmacy and associated terms were obtained. There were 111 numerical only definitions (80.4% of all definitions), 15 numerical definitions which incorporated a duration of therapy or healthcare setting (10.9%) and 12 descriptive definitions (8.7%).` The review's unit of analysis is the definition - the only paper in this corpus whose object of study is what we tag | mechanisms[0] | 0.95 | the tagger's words |
| mechanisms | AND THE THRESHOLD VARIES FIVE-FOLD: `there was variation with regard to the actual definition of polypharmacy, which ranged from two or more medications to 11 OR MORE MEDICATIONS. The most commonly used definition for polypharmacy was five or more medications daily, with 46.4% (n = 51) of studies using this definition.` The modal definition is used by FEWER THAN HALF the studies, so the majority of the literature disagrees with the majority definition | mechanisms[1] | 0.95 | the tagger's words |
| mechanisms | AND 109 OF THE 110 DID NOT NOTICE: `Of the 110 studies included in the review, only one highlighted the inconsistencies in the definitions of polypharmacy in the literature.` And that one study's own definition is not about the number of drugs at all - it defines polypharmacy as `Patients visiting multiple pharmacies to obtain medications`. The only author who noticed the disagreement was using a different REFERENT from everyone else | mechanisms[2] | 0.95 | the tagger's words |
| mechanisms | AND THE NUMBER HAS NO STATED CLINICAL BASIS: `the clinical basis for using a numerical count such as five or more medications to define polypharmacy and the potential of this to rationalise medication use and optimise health outcomes is not elucidated in most studies.` A threshold in universal use whose derivation is unstated wherever it is used | mechanisms[3] | 0.95 | the tagger's words |
| mechanisms | AND THE COUNT DOES NOT MEASURE THE THING ANYONE CARES ABOUT: `the specific number of drugs taken is not itself indicative of appropriateness of therapy as all of the drugs may be clinically necessary and appropriate for the patient` - and one cited author goes further: `when each of the medications can be linked to practice guidelines for chronic conditions for a given patient, using a numerical cut-off to define polypharmacy becomes irrelevant` | mechanisms[4] | 0.95 | the tagger's words |
| mechanisms | AND THE PROPOSED REPAIR IS A NEW TERM, NOT A BETTER NUMBER: `There is a clear need towards adopting the term `APPROPRIATE POLYPHARMACY` in order to differentiate between the prescribing of `MANY` AND `TOO MANY` drugs instead of a simple numerical count of medications, which is of limited value in practice.` The literature's answer to an unusable threshold is a qualitative term - and only 6.4% of the 110 studies make that distinction at all | mechanisms[5] | 0.95 | the tagger's words |
| mechanisms | AND ADDING PRECISION DID NOT ADD AGREEMENT: `Whilst the addition of duration of therapy or healthcare setting to a count of medicines in the definition of polypharmacy provided more specific definitions, it did not provide any further clarity or consistency.` A more precise definition is not a more agreed one - and the review says the extra precision came from `the dispensing data available`, not from a clinical argument | mechanisms[6] | 0.95 | the tagger's words |
| mechanisms | AND THE REVIEW DOES SYNONYMY ON ITS OWN COLLECTION: `Some studies used different wording but conveyed the same definition of polypharmacy. For example, the definitions `Co-prescribing multiple medications` and `Simultaneous and long term use of different drugs by the same individual` describe polypharmacy as the use of multiple medications concurrently.` Two surface forms collapsed to one sense, by hand, inside a review of definitions | mechanisms[7] | 0.95 | the tagger's words |
| mechanisms | AND A SUB-TERM IS FLAGGED AS UNDEFINED BY THE REVIEWERS THEMSELVES (Table 4): `Rational polypharmacy recognizes legitimate prescribing and indiscriminate prescribing suggests inappropriate prescribing (the terms `LEGITIMATE PRESCRIBING` AND `INAPPROPRIATE PRESCRIBING` were not explained).` A definition built entirely out of two terms its own author leaves undefined - the literature's version of this project's rule that a definer never fixes their own terms | mechanisms[8] | 0.95 | the tagger's words |
| mechanisms | AND THERE IS A NAME FOR THE RECORD DISAGREEING WITH THE WORLD (Table 4): `PSEUDOPOLYPHARMACY - Patients being recorded as taking more medications than they are actually taking.` A data-quality problem promoted to a named clinical term, in a literature that cannot agree what the unmodified term means | mechanisms[9] | 0.95 | the tagger's words |
| mechanisms | THE COUNT OF DEFINITIONS EXCEEDS THE COUNT OF PAPERS, AND THE REASON IS COINAGE: `Articles not only defined polypharmacy but associated terms such as minor and major polypharmacy. As a result, a total of 138 definitions ... were obtained` from 110 articles. A field asked to define one term produces more terms, and each new term needs its own definition. | mechanisms[10] | 0.95 | the tagger's words |
| mechanisms | AND THE DISTINCTION THAT WOULD MAKE THE TERM USEFUL IS DRAWN BY ONE ARTICLE IN SIXTEEN: `Only 6.4% of articles classified the distinction between appropriate and inappropriate polypharmacy, using descriptive definitions to make this distinction.` The 93.6% that count pills cannot express it - a numerical threshold has no place to put `appropriate`. | mechanisms[11] | 0.95 | the tagger's words |
| limitations | THE REVIEW'S OWN BOUNDS: `A limitation of this review is the inclusion of studies in English only which can cause information bias. While EMABSE, MEDLINE (Ovid) and Cochrane databases were searched, the absence of other databases such as Scopus could have introduced selection bias. Additionally articles from the year 2000 until present have been included. There may be clinically relevant definitions for polypharmacy which were added to literature prior to 2000.` So 138 is a floor, and the count of definitions is itself bounded by a search | limitations[0] | 0.95 | the tagger's words |
| limitations | AND ONLY 6.4% MAKE THE DISTINCTION THE REVIEW ARGUES FOR: `ONLY SEVEN STUDIES (6.4% OF ALL STUDIES) defined appropriate or rational polypharmacy, or recognised the distinction between appropriate and inappropriate medications. These studies either defined polypharmacy using a brief description only (n = 3) or used a brief description and polypharmacy tools such as the Beers criteria and the Medication Appropriateness Index (n = 4).` The alternative to the number is a published list, and four studies used one | limitations[1] | 0.95 | the tagger's words |
| limitations | and the conclusion is a request rather than a result: `definitions are variable, which can cause confusion for researchers as well as clinicians in practice. Numerical definitions of polypharmacy do not account for specific comorbidities present and make it difficult to assess safety and appropriateness of therapy in the clinical setting. There is a need for an internationally agreed definition of polypharmacy.` Written in 2017; cruz-jentoft2010 wrote the same sentence about sarcopenia in 2010 and kirk2024 was still writing it in 2024 | limitations[2] | 0.95 | the tagger's words |
| limitations | THE REVIEW'S OWN VERDICT ON ITS FIELD, IN ITS CONCLUSIONS: `Polypharmacy definitions were variable. Numerical definitions of polypharmacy did not account for specific comorbidities present and make it difficult to assess safety and appropriateness of therapy in the clinical setting.` The dominant definition type is judged unfit for the clinical decision the term exists to inform. | limitations[3] | 0.95 | the tagger's words |
| controls | a PRISMA-conforming protocol with three databases plus grey literature, a pre-defined extraction template, and three reviewers deciding inclusion by consensus eliminates: a selective collection of definitions chosen to make the point · outcome: held | controls[0] | 0.95 | the tagger's words |
| controls | classifying every definition as numerical only / numerical with duration or setting / descriptive before comparing them eliminates: counting two definitions as different when they differ only in wording - the review checks this explicitly and finds cases · outcome: partial | controls[1] | 0.95 | the tagger's words |
| controls | restricting to English-language articles published from 2000 eliminates: nothing - it is a bound the review declares rather than a control · outcome: failed | controls[2] | 0.95 | the tagger's words |
| concepts | polypharmacy also in: polypharmacy | concepts[0] | 0.95 | the paper's words |
| concepts | appropriate polypharmacy also in: appropriate polypharmacy | concepts[1] | 0.95 | the paper's words |
| concepts | numerical count also in: numerical count | concepts[2] | 0.95 | the paper's words |
| concepts | five or more medications also in: five or more medications | concepts[3] | 0.95 | the paper's words |
| concepts | number of drugs also in: number of drugs | concepts[4] | 0.95 | the paper's words |
| concepts | appropriateness of therapy also in: appropriateness of therapy | concepts[5] | 0.95 | the paper's words |
| concepts | pseudopolypharmacy also in: pseudopolypharmacy | concepts[6] | 0.95 | the paper's words |
| concepts | minor and major polypharmacy also in: minor and major polypharmacy | concepts[7] | 0.95 | the paper's words |
| senses | `polypharmacy` (numerical, 80.4% of definitions) - a count of medications, threshold anywhere from TWO OR MORE to ELEVEN OR MORE; five or more in 46.4% of studies | senses[0] | 0.95 | the tagger's words |
| senses | `polypharmacy` (numerical with duration or setting, 10.9%) - the same counts qualified by a period or a place, e.g. five or more at hospital discharge; `it did not provide any further clarity or consistency` | senses[1] | 0.95 | the tagger's words |
| senses | `polypharmacy` (descriptive, 8.7%) - `more drugs being prescribed or taken than are clinically appropriate in the context of a patient's comorbidities`, and at the other extreme `Patients visiting multiple pharmacies to obtain medications` - a different referent entirely | senses[2] | 0.95 | the tagger's words |
| senses | `appropriate polypharmacy` - the term proposed to separate `MANY` from `too many`; defined explicitly by one study out of 110 | senses[3] | 0.95 | the tagger's words |
| senses | `pseudopolypharmacy` - `patients being RECORDED as taking more medications than they are ACTUALLY taking`: the record, not the patient | senses[4] | 0.95 | the tagger's words |
| senses | `polypharmacy` - DECLARED TO HAVE NO AGREED MEANING, IN THE ABSTRACT OF A REVIEW ABOUT ITS MEANINGS: `Despite this, there is no consensus definition for polypharmacy. A systematic review was conducted to identify and summarise polypharmacy definitions in existing literature.` The absence of a definition is the paper's stated reason to exist. | senses[5] | 0.95 | the tagger's words |
| claim_relations | critiques → the numerical definitions of polypharmacy used by 80.4% of the definitions reviewed, whose clinical basis 'is not elucidated in most studies' and which 'do not account for specific comorbidities present' | claim_relations[0] | 0.95 | the tagger's words |
| claim_relations | extends → the single reviewed study that itself highlighted the inconsistency in polypharmacy definitions - one of 110 | claim_relations[1] | 0.95 | the tagger's words |
| concept_edges | polypharmacy —operationalised-as→ five or more medications the relation itself is separately evidenced · strength of the relation: 0.95 · note: 'The most commonly used term was polypharmacy which was defined as five or more medications by 46.4% of studies (51 articles).' The edge records the majority operationalisation and the fact that it is a MINORITY of the literature - 53.6% of these studies operationalise the same word differently · the relation stated: the modal operational definition, used by 46.4% of 110 studies, against a range running from two or more to eleven or more
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but attributed: the span reports the definition used by 46.4% of reviewed studies. also in: polypharmacy · five or more medications | concept_edges[0] | 0.95 | the tagger's words |
| concept_edges | appropriate polypharmacy —distinct-from→ numerical count the relation itself is separately evidenced · strength of the relation: 0.95 · note: `adopting the term `APPROPRIATE POLYPHARMACY` in order to differentiate between the prescribing of `MANY` AND `TOO MANY` drugs instead of a simple numerical count of medications, which is of limited value in practice.` A literature answering an unusable threshold with a qualitative term rather than a better number · the relation stated: the proposed term is offered INSTEAD OF the count, to separate 'many' from 'too many' also in: appropriate polypharmacy · numerical count | concept_edges[1] | 0.85 | the tagger's words |
| concept_edges | number of drugs —distinct-from→ appropriateness of therapy the relation itself is separately evidenced · strength of the relation: 0.95 · note: 'the specific number of drugs taken is not itself indicative of appropriateness of therapy as all of the drugs may be clinically necessary and appropriate for the patient.' The gap between what is counted and what is meant, stated by the reviewers in one sentence - and, elsewhere in the paper, 80.4% of the definitions in the corpus they reviewed count the first and mean the second · the relation stated: the measured quantity is NOT INDICATIVE of the property the definition is supposed to identify also in: number of drugs · appropriateness of therapy | concept_edges[2] | 0.95 | the tagger's words |
| content_tags | 138 DEFINITIONS OF ONE TERM AND ITS FAMILY, FROM 110 ARTICLES: `111 NUMERICAL ONLY (80.4%), 15 numerical with A duration of therapy or healthcare setting (10.9%) and 12 DESCRIPTIVE (8.7%)` | content_tags.findings[0] | 0.95 | the tagger's words |
| content_tags | AND THE THRESHOLD VARIES FIVE-FOLD, WITH THE MODAL DEFINITION IN A MINORITY: `ranged from two or more medications to 11 OR MORE MEDICATIONS. The most commonly used definition ... was five or more medications daily, with 46.4% (n = 51) of studies using this definition` | content_tags.findings[1] | 0.95 | the tagger's words |
| content_tags | only one of 110 studies highlighted the inconsistent definitions, proposing polypharmacy be defined as patients visiting multiple pharmacies | content_tags.findings[2] | 0.95 | the tagger's words |
| content_tags | AND THE NUMBER'S CLINICAL BASIS IS UNSTATED WHEREVER IT IS USED: `the clinical basis for using a numerical count such as five or more medications ... is not elucidated in most studies` | content_tags.findings[3] | 0.95 | the tagger's words |
| content_tags | AND ADDING PRECISION DID NOT ADD AGREEMENT: `the addition of duration of therapy or healthcare setting ... provided more specific definitions, it did not provide any further clarity or consistency` | content_tags.findings[4] | 0.95 | the tagger's words |
| content_tags | AND A DEFINITION BUILT FROM TWO UNDEFINED TERMS, FLAGGED BY THE REVIEWERS (Table 4): `Rational polypharmacy recognizes legitimate prescribing and indiscriminate prescribing suggests inappropriate prescribing (the terms `LEGITIMATE PRESCRIBING` AND `INAPPROPRIATE PRESCRIBING` were not explained)` | content_tags.findings[5] | 0.95 | the tagger's words |
| content_tags | `five or more medications daily`, used by 46.4% (n = 51) of 110 studies - a plurality, not a majority also in: polypharmacy | content_tags.definitions[0] | 0.95 | the tagger's words |
| content_tags | `Patients being recorded as taking more medications than they are actually taking` (Table 4) - the discrepancy between record and world, named also in: pseudopolypharmacy | content_tags.definitions[1] | 0.95 | the tagger's words |
| content_tags | the term proposed `to differentiate between the prescribing of `MANY` AND `TOO MANY` DRUGS instead of a simple numerical count`; explicitly defined by ONE of the 110 studies also in: appropriate polypharmacy | content_tags.definitions[2] | 0.95 | the tagger's words |
| content_tags | 111 numerical only (80.4%), 15 numerical with duration or setting (10.9%), 12 descriptive (8.7%) | content_tags.quantities[0] | 0.95 | the tagger's words |
| content_tags | a five-fold spread on the same word, across one literature and one 16-year window | content_tags.quantities[1] | 0.95 | the tagger's words |
| content_tags | the most common definition of polypharmacy is used by fewer than half the studies that define it | content_tags.quantities[2] | 0.95 | the tagger's words |
| content_tags | `only one highlighted the inconsistencies in the definitions of polypharmacy in the literature` | content_tags.quantities[3] | 0.95 | the tagger's words |
| content_tags | four of the seven used a published list - the Beers criteria - rather than a definition of their own | content_tags.quantities[4] | 0.95 | the tagger's words |
| content_tags | the review's only statistic: how many of the 110 articles use each definition, which is what turns a disagreement into a measurable one also in: percentage of studies | content_tags.statistics[0] | 0.95 | the tagger's words |
| content_tags | the quantity 80.4% of the definitions are built on, and the one the review argues does not indicate what clinicians need to know also in: number of medications | content_tags.variables[0] | 0.95 | the tagger's words |
Tags that could not be placed in the text:
What was deliberately not tagged, and why, is recorded per paper by the tagger. Where a paper has no such record, this page says so rather than implying that nothing was declined.